In cancer, constitutive Wnt signaling can be achieved, for example, by loss‐of‐function mutations in the components of the degradation complex adenomatous polyposis coli (APC) and Axin1, which are major tumor suppressors in colorectal and hepatocellular cancer, respectively. This evidence concerns the gene APC and hepatocellular carcinoma.